Biotech Evotec Secures $2.9 Million Grant to Advance Early Drug Safety Testing Using Human Stem Cell Technology November 16, 2026
Biotech Lexeo Therapeutics to Report Third Quarter 2026 Financial Results and Provide LX2020 Business Update on November 16, 2026 November 15, 2026
Biotech Cocrystal Pharma Provides Business Update and Reports Third Quarter 2026 Financial Results November 15, 2026
Biotech HUTCHMED Announces Expanded Coverage on National Reimbursement Drug List for ELUNATE® and ORPATHYS® November 15, 2026
Biotech Viking Therapeutics Highlights Clinical Data from VK2735 Obesity Program at ObesityWeek® 2026 November 15, 2026
Biotech IDEAYA Biosciences Announces Development Candidate Nomination of IDE101, a Potential First-In-Class Inhibitor Targeting CDKN2A-Deficiency in Solid Tumors November 15, 2026
Biotech Immunic, Inc. Reports Third Quarter 2026 Financial Results and Provides Corporate Update November 14, 2026
Biotech TuHURA Biosciences Reports Third Quarter 2026 Financial Results and Provides a Corporate Update November 13, 2026